Development and validation of a UPLC-MS/MS method for simultaneous detection of doxorubicin and sorafenib in plasma: Application to pharmacokinetic studies in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and validation of a UPLC-MS/MS method for simultaneous detection of doxorubicin and sorafenib in plasma: Application to pharmacokinetic studies in rats

Published:2023-07 Issue:7 Volume:31 Page:1317-1326
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Altalal Alanoud,Almomen Aliyah,Alkholief Musaed,Binkhathlan Ziyad,Alzoman Nourah Z.,Alshamsan Aws

Funder

King Saud University

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference30 articles.

1. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial;Abou-Alfa;JAMA,2010

2. Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: Phase 3 CALGB 80802 randomized clinical trial;Abou-Alfa;JAMA Oncol.,2019

3. Sorafenib (BAY 43–9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature;Adnane;MethodsEnzymol.,2006

4. Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin;Binkhathlan;Eur. J. Pharm. Biopharm.,2012

5. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model;Christowitz;BMC Cancer,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP